Combined Effects of Doxorubicin and Temozolomide in Cultured Glioblastoma Cells

The oncological field benefits of extensive medical research and various types of cancer notice improvements, however glioblastoma multiforme remains one of the deadliest cancers in humans with virtually no advance in survival and clinical outcome. Temozolomide, the FDA approved drug for glioblastom...

Descripción completa

Detalles Bibliográficos
Autores principales: BALOI, CARINA, OPRITA, ALEXANDRU, SEMENESCU, LILIANA ELEONORA, TACHE, DANIELA ELISE, POPESCU, OANA STEFANA, STAICU, GEORGIANA ADELINE, DRICU, ANICA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical University Publishing House Craiova 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940925/
https://www.ncbi.nlm.nih.gov/pubmed/36815076
http://dx.doi.org/10.12865/CHSJ.48.03.03

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940925/
https://www.ncbi.nlm.nih.gov/pubmed/36815076
http://dx.doi.org/10.12865/CHSJ.48.03.03

Ejemplares similares